guest ::
| Home > Publications database > Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma. > print |
| Home > Publications database > Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma. > print |
| 001 | 127660 | ||
| 005 | 20240228140942.0 | ||
| 024 | 7 | _ | |a 10.1007/s00066-015-0825-3 |2 doi |
| 024 | 7 | _ | |a pmid:25737378 |2 pmid |
| 024 | 7 | _ | |a 0039-2073 |2 ISSN |
| 024 | 7 | _ | |a 0179-7158 |2 ISSN |
| 024 | 7 | _ | |a 1439-099X |2 ISSN |
| 037 | _ | _ | |a DKFZ-2017-03683 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Uhl, Matthias |b 0 |
| 245 | _ | _ | |a Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma. |
| 260 | _ | _ | |a Heidelberg |c 2015 |b Springer51814 |
| 264 | _ | 1 | |3 online |2 Crossref |b Springer Science and Business Media LLC |c 2015-03-04 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2015-07-01 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2015-07-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1524140042_24121 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a The purpose of this work was to evaluate the results of high-dose radiation treatment using carbon ion therapy, alone or combined with intensity-modulated radiation treatment (IMRT), in patients with sacral chordoma.Between 2009 and 2012, 56 patients with sacral chordoma were treated in our center. The tumor was located above S3 in 33 patients and in S3 or below in 23 patients. In all, 41 patients received radiation therapy for the primary tumor, while 15 patients were treated for the recurrent tumor. Toxicity was measured using NCI CTCAE v.4.03. Local control (LC) and overall survival (OS) were evaluated with the Kaplan-Meier method.A total of 23 patients were irradiated with carbon ions in combination with photon IMRT, while 33 received carbon ion therapy only. Forty-three patients had a macroscopic tumor at treatment start with a median tumor size (GTV) of 244 ml (range 5-1188 ml). The median total dose was 66 Gy (range 60-74 Gy; RBE). After a median follow-up time of 25 months, the 2- and 3-year local control probability was 76 % and 53 %, respectively. The overall survival rate was 100 %. Treatment for primary tumor and male patients resulted in significant better local control. No higher toxicity occurred within the follow-up time.High-dose photon/carbon ion beam radiation therapy is safe and, especially for primary sacral chordomas, highly effective. A randomized trial is required to evaluate the role of primary definitive hypofractionated particle therapy compared with surgery with or without adjuvant radiotherapy. |
| 536 | _ | _ | |a 315 - Imaging and radiooncology (POF3-315) |0 G:(DE-HGF)POF3-315 |c POF3-315 |f POF III |x 0 |
| 542 | _ | _ | |i 2015-03-04 |2 Crossref |u http://www.springer.com/tdm |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Welzel, Thomas |b 1 |
| 700 | 1 | _ | |a Jensen, Alexandra |b 2 |
| 700 | 1 | _ | |a Ellerbrock, Malte |b 3 |
| 700 | 1 | _ | |a Haberer, Thomas |b 4 |
| 700 | 1 | _ | |a Jäkel, Oliver |0 P:(DE-He78)440a3f62ea9ea5c63375308976fc4c44 |b 5 |u dkfz |
| 700 | 1 | _ | |a Herfarth, Klaus |b 6 |
| 700 | 1 | _ | |a Debus, Jürgen |0 P:(DE-He78)8714da4e45acfa36ce87c291443a9218 |b 7 |e Last author |u dkfz |
| 773 | 1 | 8 | |a 10.1007/s00066-015-0825-3 |b Springer Science and Business Media LLC |d 2015-03-04 |n 7 |p 597-603 |3 journal-article |2 Crossref |t Strahlentherapie und Onkologie |v 191 |y 2015 |x 0179-7158 |
| 773 | _ | _ | |a 10.1007/s00066-015-0825-3 |g Vol. 191, no. 7, p. 597 - 603 |0 PERI:(DE-600)2003907-4 |n 7 |p 597-603 |t Strahlentherapie und Onkologie |v 191 |y 2015 |x 0179-7158 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:127660 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)440a3f62ea9ea5c63375308976fc4c44 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)8714da4e45acfa36ce87c291443a9218 |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-315 |2 G:(DE-HGF)POF3-300 |v Imaging and radiooncology |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b STRAHLENTHER ONKOL : 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 920 | 1 | _ | |0 I:(DE-He78)E040-20160331 |k E040 |l Medizinische Physik in der Strahlentherapie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)E050-20160331 |k E050 |l KKE Strahlentherapie |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)L101-20160331 |k L101 |l DKTK Heidelberg |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)E040-20160331 |
| 980 | _ | _ | |a I:(DE-He78)E050-20160331 |
| 980 | _ | _ | |a I:(DE-He78)L101-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| 999 | C | 5 | |a 10.1002/path.1711710112 |9 -- missing cx lookup -- |1 JR Salisbury |p 59 - |2 Crossref |u Salisbury JR, Deverell MH, Cookson MJ et al (1993) Three-dimensional reconstruction of human embryonic notochords: clue to the pathogenesis of chordoma. J Pathol 171:59–62 |t J Pathol |v 171 |y 1993 |
| 999 | C | 5 | |a 10.1002/cncr.28032 |9 -- missing cx lookup -- |2 Crossref |u Smoll NR, Gautschi OP, Radovanovic et al (2013) Incidence and relative survival of chordomas: the standardized mortality ratio and the impact of chordomas on a population. Cancer 119:2029–2037 |
| 999 | C | 5 | |a 10.1038/sc.2009.95 |9 -- missing cx lookup -- |1 KW Chen |p 166 - |2 Crossref |u Chen KW, Yang HL, Lu J et al (2010) Prognostic factors of sacral chordoma after surgical therapy: a study of 36 patients. Spinal Cord 48:166–171 |t Spinal Cord |v 48 |y 2010 |
| 999 | C | 5 | |a 10.1097/00007632-199908150-00004 |9 -- missing cx lookup -- |1 EY Cheng |p 1639 - |2 Crossref |u Cheng EY, Ozerdemoglu RA, Transfeldt EE et al (1999) Lumbosacral chordoma. Prognostic factors and treatment. Spine (Phila Pa 1976) 24:1639–1645 |t Spine |v 24 |y 1999 |
| 999 | C | 5 | |a 10.2106/JBJS.D.02693 |9 -- missing cx lookup -- |1 B Fuchs |p 2211 - |2 Crossref |u Fuchs B, Dickey ID, Yaszemski MJ et al (2005) Operative management of sacral chordoma. J Bone Joint Surg Am 87:2211–2216 |t J Bone Joint Surg Am |v 87 |y 2005 |
| 999 | C | 5 | |a 10.1007/s00432-005-0067-3 |9 -- missing cx lookup -- |1 S Osaka |p 213 - |2 Crossref |u Osaka S, Kodoh O, Sugita H et al (2006) Clinical significance of a wide excision policy for sacrococcygeal chordoma. J Cancer Res Clin Oncol 132:213–218 |t J Cancer Res Clin Oncol |v 132 |y 2006 |
| 999 | C | 5 | |a 10.1097/00007632-197812000-00009 |9 -- missing cx lookup -- |1 B Stener |p 351 - |2 Crossref |u Stener B, Gunterberg B (1978) High amputation of the sacrum for extirpation of tumors. Principles and technique. Spine (Phila Pa 1976) 3:351–366 |t Spine |v 3 |y 1978 |
| 999 | C | 5 | |a 10.1002/jso.20477 |9 -- missing cx lookup -- |1 C Devin |p 203 - |2 Crossref |u Devin C, Chong PY, Holt GE et al (2006) Level-adjusted perioperative risk of sacral amputations. J Surg Oncol 94:203–211 |t J Surg Oncol |v 94 |y 2006 |
| 999 | C | 5 | |a 10.1097/BRS.0b013e3181b61b90 |9 -- missing cx lookup -- |1 PC Hsieh |p 2233 - |2 Crossref |u Hsieh PC, Xu R, Sciubba DM et al (2009) Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients. Spine (Phila Pa 1976) 34:2233–2239 |t Spine |v 34 |y 2009 |
| 999 | C | 5 | |1 KM Davidge |y 2010 |2 Crossref |u Davidge KM, Eskicioglu C, Lipa J et al (2010) Qualitative assessment of patient experiences following sacrectomy. J Surg Oncol 101:447–450 |
| 999 | C | 5 | |a 10.2106/JBJS.D.02533 |9 -- missing cx lookup -- |1 CA Hulen |p 1532 - |2 Crossref |u Hulen CA, Temple HT, Fox WP et al (2006) Oncologic and functional outcome following sacrectomy for sacral chordoma. J Bone Joint Surg Am 88:1532–1539 |t J Bone Joint Surg Am |v 88 |y 2006 |
| 999 | C | 5 | |a 10.1097/00006123-199901000-00041 |9 -- missing cx lookup -- |1 JE York |p 74 - |2 Crossref |u York JE, Kaczaraj A, Abi-Said D et al (1999) Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery 44:74–79; discussion 9–80 |t Neurosurgery |v 44 |y 1999 |
| 999 | C | 5 | |a 10.1007/s00066-014-0604-6 |9 -- missing cx lookup -- |1 SU Lee |p 806 - |2 Crossref |u Lee SU, Park JW, Kim TH et al (2014) Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Strahlenther Onkol 190:806–814 |t Strahlenther Onkol |v 190 |y 2014 |
| 999 | C | 5 | |a 10.1007/s00066-013-0489-9 |9 -- missing cx lookup -- |1 Y Demizu |p 186 - |2 Crossref |u Demizu Y, Fujii O, Terashima K et al (2014) Particle therapy for mucosal melanoma of the head and neck. A single-institution retrospective comparison of proton and carbon ion therapy. Strahlenther Onkol 190:186–191 |t Strahlenther Onkol |v 190 |y 2014 |
| 999 | C | 5 | |a 10.1007/s00066-013-0390-6 |9 -- missing cx lookup -- |1 M Mizumoto |p 656 - |2 Crossref |u Mizumoto M, Okumura T, Ishikawa E et al (2013) Reirradiation for recurrent malignant brain tumor with radiotherapy or proton beam therapy. Technical considerations based on experience at a single institution. Strahlenther Onkol 189:656–663 |t Strahlenther Onkol |v 189 |y 2013 |
| 999 | C | 5 | |a 10.1038/nrclinonc.2009.183 |9 -- missing cx lookup -- |1 M Durante |p 37 - |2 Crossref |u Durante M, Loeffler JS (2010) Charged particles in radiation oncology. Nat Rev Clin Oncol 7:37–43 |t Nat Rev Clin Oncol |v 7 |y 2010 |
| 999 | C | 5 | |a 10.1002/cncr.28606 |9 -- missing cx lookup -- |1 M Uhl |p 1579 - |2 Crossref |u Uhl M, Mattke M, Welzel T et al (2014) High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: first report of long-term results. Cancer 120:1579–1585 |t Cancer |v 120 |y 2014 |
| 999 | C | 5 | |a 10.1002/cncr.28877 |9 -- missing cx lookup -- |1 M Uhl |p 3410 - |2 Crossref |u Uhl M, Mattke M, Welzel T et al (2014) Highly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: first long-term results. Cancer 120:3410–3417 |t Cancer |v 120 |y 2014 |
| 999 | C | 5 | |a 10.1186/1748-717X-9-100 |9 -- missing cx lookup -- |1 M Uhl |p 100 - |2 Crossref |u Uhl M, Edler L, Jensen AD et al (2014) Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma—the ISAC trial protocol. Radiat Oncol 9:100 |t Radiat Oncol |v 9 |y 2014 |
| 999 | C | 5 | |a 10.1002/cncr.21158 |9 -- missing cx lookup -- |1 D Schulz-Ertner |p 338 - |2 Crossref |u Schulz-Ertner D, Nikoghosyan A, Didinger B et al (2005) Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer 104:338–344 |t Cancer |v 104 |y 2005 |
| 999 | C | 5 | |a 10.1007/s00066-014-0608-2 |9 -- missing cx lookup -- |1 M Uhl |p 686 - |2 Crossref |u Uhl M, Welzel T, Oelmann J et al (2014) Active raster scanning with carbon ions: reirradiation in patients with recurrent skull base chordomas and chondrosarcomas. Strahlenther Onkol 190:686–691 |t Strahlenther Onkol |v 190 |y 2014 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2006.02.059 |9 -- missing cx lookup -- |1 L Park |p 1514 - |2 Crossref |u Park L, Delaney TF, Liebsch NJ et al (2006) Sacral chordomas: impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys 65:1514–1521 |t Int J Radiat Oncol Biol Phys |v 65 |y 2006 |
| 999 | C | 5 | |a 10.1097/BRS.0b013e318296e7d7 |9 -- missing cx lookup -- |1 YL Chen |p E930 - |2 Crossref |u Chen YL, Liebsch N, Kobayashi W et al (2013) Definitive high-dose photon/proton radiotherapy for unresected mobile spine and sacral chordomas. Spine (Phila Pa 1976) 38:E930–E936 |t Spine |v 38 |y 2013 |
| 999 | C | 5 | |a 10.1259/bjr.20130512 |9 -- missing cx lookup -- |1 M Mima |p 20130512 - |2 Crossref |u Mima M, Demizu Y, Jin D et al (2014) Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma. Br J Radiol 87:20130512 |t Br J Radiol |v 87 |y 2014 |
| 999 | C | 5 | |a 10.1259/bjr/13783281 |9 -- missing cx lookup -- |1 R Imai |p S48 - |2 Crossref |u Imai R, Kamada T, Sugahara S et al (2011) Carbon ion radiotherapy for sacral chordoma. Br J Radiol 84:Spec No 1:S48–S54 |t Br J Radiol |v 84 |y 2011 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2008.08.058 |9 -- missing cx lookup -- |1 TF DeLaney |p 732 - |2 Crossref |u DeLaney TF, Liebsch NJ, Pedlow FX et al (2009) Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys 74:732–739 |t Int J Radiat Oncol Biol Phys |v 74 |y 2009 |
| 999 | C | 5 | |a 10.1016/j.radonc.2009.08.041 |9 -- missing cx lookup -- |1 T Yanagi |p 60 - |2 Crossref |u Yanagi T, Kamada T, Tsuji H et al (2010) Dose-volume histogram and dose-surface histogram analysis for skin reactions to carbon ion radiotherapy for bone and soft tissue sarcoma. Radiother Oncol 95:60–65 |t Radiother Oncol |v 95 |y 2010 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2011.02.018 |9 -- missing cx lookup -- |1 A Staab |p e489 - |2 Crossref |u Staab A, Rutz HP, Ares C et al (2011) Spot-scanning-based proton therapy for extracranial chordoma. Int J Radiat Oncol Biol Phys 81:e489–e496 |t Int J Radiat Oncol Biol Phys |v 81 |y 2011 |
| 999 | C | 5 | |a 10.1016/j.radonc.2010.10.008 |9 -- missing cx lookup -- |1 A Zabel-du Bois |p 408 - |2 Crossref |u Zabel-du Bois A, Nikoghosyan A, Schwahofer A et al (2010) Intensity modulated radiotherapy in the management of sacral chordoma in primary versus recurrent disease. Radiother Oncol 97:408–412 |t Radiother Oncol |v 97 |y 2010 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|